S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
S&P 500   4,686.75
DOW   35,719.43
QQQ   397.83
NASDAQ:AIKI

AIkido Pharma SEC Filings & 10K Form

$0.70
+0.01 (+1.71%)
(As of 12/7/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.68
$0.71
50-Day Range
$0.67
$0.88
52-Week Range
$0.55
$2.55
Volume
2.19 million shs
Average Volume
7.42 million shs
Market Capitalization
$62.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.42

AIkido Pharma (NASDAQ:AIKI) SEC Filings

DateFilerForm TypeView
06/23/2021
2:00 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2021
8:00 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2021
8:00 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
12:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2021
8:00 AM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Hayes Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
8:00 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
10:10 AM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Hayes Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2021
10:30 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form RW
04/16/2021
4:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2021
4:15 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Wool Kyle Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/13/2021
4:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2021
8:00 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
1:55 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
FiveT Investment Management Ltd (Filed by)
Form SC 13D
02/25/2021
8:41 AM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
02/18/2021
4:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
02/18/2021
4:05 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
4:41 PM
AIkido Pharma (Reporting)
AIkido Pharma (Reporting)
Hoth Therapeutics, Inc. (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/16/2021
8:41 AM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
02/03/2021
3:31 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
3:33 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
3:50 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
LeMire Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:41 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
VanderZanden Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:40 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Hayes Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:35 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
LEDWICK TIM S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
3:33 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Dudley Robert Frederick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
2:23 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/04/2020
3:24 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
11/25/2020
1:25 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
11/20/2020
7:01 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
3:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/05/2020
3:43 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEF 14A
09/29/2020
3:05 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2020
4:04 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form PRE 14A
09/14/2020
3:57 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
3:17 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2020
3:26 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2020
4:26 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-1/A
08/17/2020
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/25/2020
8:54 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
11:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form EFFECT
06/12/2020
2:20 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-3/A
06/08/2020
2:03 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-3/A
05/19/2020
4:35 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Dudley Robert Frederick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2020
4:33 PM
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
LeMire Paul (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/11/2020
4:05 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/24/2020
12:02 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
04/23/2020
7:31 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
Altium Capital Management LP (Filed by)
Form SC 13G
04/20/2020
7:30 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2020
12:11 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
04/14/2020
12:36 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
03/26/2020
2:54 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2020
2:53 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2020
1:28 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2020
5:03 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
AIkido Pharma (Subject)
AIkido Pharma (Subject)
Form SC 13G
03/10/2020
4:25 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
11:39 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
03/09/2020
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2020
9:55 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
11:15 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form EFFECT
02/28/2020
11:54 AM
Hoth Therapeutics, Inc. (Issuer)
AIkido Pharma (Reporting)
AIkido Pharma (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
01/31/2020
3:29 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/14/2020
3:33 PM
CBM BioPharma, Inc. (Filed by)
AIkido Pharma (Subject)
AIkido Pharma (Subject)
Form SC 13D
12/10/2019
9:00 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
3:57 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/11/2019
1:45 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2019
3:32 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:45 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:43 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
08/19/2019
4:27 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
4:25 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
08/09/2019
6:33 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
6:31 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
08/09/2019
4:31 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
07/24/2019
4:28 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEF 14A
06/19/2019
7:17 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
7:15 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
06/18/2019
8:57 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form PRE 14A
06/07/2019
7:03 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K/A
06/07/2019
7:01 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
05/31/2019
3:54 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:22 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 424B5
05/16/2019
7:19 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2019
7:18 AM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFA14A
05/15/2019
4:05 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2019
4:06 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form DEFR14A
02/27/2019
8:59 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form PRE 14A
02/06/2019
3:30 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2019
3:45 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2018
4:16 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2018
7:06 AM
LEDWICK TIM S (Reporting)
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2018
7:01 AM
Hayes Anthony (Reporting)
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2018
1:32 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2018
3:32 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
3:30 PM
AIkido Pharma (Subject)
AIkido Pharma (Subject)
Form 425
05/09/2018
3:00 PM
AIkido Pharma (Filer)
AIkido Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2018
7:22 PM
Blattner Gregory James (Reporting)
AIkido Pharma (Issuer)
AIkido Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.